Aziyo Biologics Inc - Ordinary Shares - Class A

NASDAQ:AZYO  
6.70
-0.37 (-5.23%)
Officer Changes, Other Pre-Announcement

Aziyo Biologics Appoints Randal Mills As Interim President And CEO

Published: 06/21/2022 20:37 GMT
Aziyo Biologics Inc - Ordinary Shares - Class A (AZYO) - Aziyo Biologics Appoints Dr.
C. Randal Mills As Interim President and Ceo.
Aziyo Biologics Inc - Ronald Lloyd Will Step Down From These Positions But Will Remain With Company Through End of Q3 to Assist With Transition.
Aziyo Biologics Inc - Aziyo Co-founder Kevin Rakin Has Also Assumed Role of Executive Chairman.
Aziyo Biologics Inc - Company Reaffirms Its Previously Provided Guidance That Total Net Sales for Full Year 2022 Will Range Between of $47 to $50 Million.